NACHC Statement in Response to New White House Measures to Fight COVID-19
September 10, 2021
MEDIA ADVISORY: NACHC to Participate in STAT News Panel Discussion about the 340B Drug Discount Program

 Contact: Amy Simmons Farber 202/309-0338 (mobile) 

NACHC’s Director of Regulatory Affairs, Vacheria Tutson, Esq., will be among the panel of experts at a STAT News stakeholder forum this week.  The two-part virtual panel discussion, moderated by Washington correspondent Rachel Cohrs, is entitled, “The 340B Drug Discount Program is at a Crossroads. What’s Next?”  The discussion will take place on Wednesday, September 15th at 1 pm EST. 

The 340B program is critical to the ability of Community Health Centers to make medications affordable for patients and to generate savings that are used to expand access to other services.  Before the program was in place, most health centers were unable to afford to provide their patients with access to discounted drugs.   By law, regulation, and mission, every penny that health centers save through 340B discounts is used either to make medication affordable for low-income patients or to support other activities that expand access to care.  Discounts from 340B have been a lifeline for health centers as they battle COVID-19 on the frontlines of hot zones across America.

NACHC is the leading advocacy voice for Community Health Centers, which serve nearly 29 million patients in medically underserved areas nationwide.  Protecting the 340B drug discount program and the benefits it provides for low-income and medically vulnerable patients is a top priority for the association.

To learn more and register for the STAT news stakeholder discussion and speakers, please visit this link.

Established in 1971, the National Association of Community Health Centers (NACHC) serves as the national voice for America’s Health Centers and as an advocate for health care access for the medically underserved and uninsured.

 

X